Eton PharmaceuticalsETON
13F holders, Q3 2024 (September 30)48holders +3
12new positions
9sold out
1famous investor
$6.00avg. 13F price*
At the end of Q3 2024, 48 institutions reported holding Eton Pharmaceuticals Inc. (ETON) in their 13F filings, up 3 from Q2 2024. 12 opened new positions and 9 sold out. The largest holders were Opaleye Management Inc. ($16.7M), Vanguard Group Inc. ($6.2M) and Nantahala Capital Management, LLC ($6.0M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Eton Pharmaceuticals Inc.
- CUSIP
- 29772L108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $6.2M |
| Exits | 9 | $792K |
All 13F filers, Q2 2024 → Q3 2024: 1,617,800 shares bought and 340,660 shares sold, net +1,277,140 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 48 holders
| Opaleye Management Inc. | 2.82% | Add +16.1% | 2,780,000 | $16.7M |
| Vanguard Group Inc. | 0.00% | No change | 1,027,688 | $6.2M |
| Nantahala Capital Management, LLC | 0.50% | Add +6.2% | 998,733 | $6.0M |
| Westside Investment Management, Inc. | 0.79% | Add +5.7% | 618,675 | $3.7M |
| Acuitas Investments, LLC | 1.55% | No change | 579,960 | $3.5M |
| EcoR1 Capital, LLC | 0.12% | New | 566,075 | $3.4M |
| National Philanthropic Trust | 0.05% | No change | 492,112 | $3.0M |
| Paradigm Capital Management Inc. | 0.08% | No change | 300,000 | $1.8M |
| BlackRock, Inc. | 0.00% | — | 284,855 | $1.7M |
| Geode Capital Management, LLC | 0.00% | Add +13.5% | 272,696 | $1.6M |
| Parkman Healthcare Partners LLC | 0.20% | Add +2.8% | 260,226 | $1.6M |
| Bridgeway Capital Management, LLC | 0.03% | No change | 253,362 | $1.5M |
| Wasatch Advisors LP | 0.01% | New | 238,565 | $1.4M |
| Aristides Capital LLC | 0.50% | No change | 200,000 | $1.2M |
| Informed Momentum Co LLC | 0.12% | New | 128,276 | $770K |
| Susquehanna International Group, LLP | 0.00% | Reduce -11.1% | 119,347 | $716K |
| Thompson Siegel & Walmsley LLC | 0.01% | Reduce -9.9% | 115,030 | $690K |
| Acadian Asset Management LLC | 0.00% | Reduce -12.1% | 105,954 | $634K |
| Renaissance Technologies | 0.00% | Reduce -21.7% | 83,400 | $500K |
| State Street Corp. | 0.00% | No change | 81,403 | $488K |
| Bank of New York Mellon Corp | 0.00% | No change | 74,491 | $447K |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | Add +86.6% | 65,014 | $390K |
| Northern Trust Corp. | 0.00% | Add +7.2% | 64,130 | $385K |
| Blair William & Co. | 0.00% | No change | 34,500 | $207K |
| Qube Research & Technologies Ltd | 0.00% | Add +808450.0% | 32,342 | $194K |
| Essex Investment Management Co. LLC | 0.03% | No change | 27,252 | $164K |
| Citigroup Inc. | 0.00% | New | 26,495 | $159K |
| Marshall Wace, LLP | 0.00% | New | 20,637 | $124K |
| UBS Group AG | 0.00% | Add +72.6% | 19,017 | $114K |
| Schonfeld Strategic Advisors LLC | 0.00% | Reduce -66.2% | 17,200 | $103K |
| CHICAGO TRUST Co NA | 0.02% | No change | 16,700 | $100K |
| Jane Street Group, LLC | 0.00% | New | 15,006 | $90K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 13,239 | $79K |
| Occudo Quantitative Strategies LP | 0.01% | New | 12,170 | $73K |
| Quantum Private Wealth, LLC | 0.02% | No change | 11,500 | $69K |
| XTX Topco Ltd | 0.00% | Reduce -3.7% | 11,304 | $68K |
| Raymond James & Associates | 0.00% | No change | 10,250 | $62K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.01% | New | 8,927 | $54K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 8,269 | $50K |
| Truvestments Capital LLC | 0.00% | New | 1,183 | $7K |
| Plante Moran Financial Advisors, LLC | 0.00% | No change | 1,000 | $6K |
| JPMorgan Chase & Co. | 0.00% | New | 723 | $4K |
| Group One Trading LLC | 0.00% | New | 722 | $4K |
| Morgan Stanley | 0.00% | Add +145.8% | 472 | $3K |
| BNP Paribas Financial Markets | 0.00% | No change | 350 | $2K |
| Royal Bank of Canada | 0.00% | Reduce -63.2% | 275 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 300 | $2K |
| Bank of America Corp. | 0.00% | Add +9.8% | 201 | $1K |
"% of holder's portfolio" is ETON's weight in each manager's 13F, not the share of Eton Pharmaceuticals Inc. the manager owns.